At the beginning of 2026, the global medical large model market is filled with intense competition. With OpenAI officially launching ChatGPT Health to enter the medical vertical field, major global tech giants have followed suit: Anthropic launched Claude for Healthcare, and Google updated MedGemma1.5, a version specifically designed for medical scenarios.

Facing the pressure from international giants, domestic medical large models have demonstrated strong "home-field advantages."

In terms of performance, domestic models have made significant breakthroughs. Among them, Baichuan Intelligence's Baichuan-M3 and M3Plus have surpassed GPT-5.2 in multiple metrics. Industry experts point out that although foreign large models are technologically advanced, in China's complex medical environment, domestic large models have irreplaceable competitiveness in localization support, policy compliance, and Chinese professional data accumulation.

Who will be the most anticipated "national light" of 2026?

MedTechNet has selected the Ten Most Promising Domestic Medical Large Models of 2026 based on dimensions such as performance iteration, industry resource reserves, and data depth. The list includes leaders from various sub-sectors:

Comprehensive Giants: Including general-purpose medical professional models from Baichuan Intelligence and Baidu.

Platform and Services: Vertical models built by Fangzhou Jianke, Ant Afu, and JD Health based on service ecosystems.

Hardcore Technology Players: Professional forces such as ShuKun Technology and DAMO Academy focusing on medical imaging and cutting-edge technologies.

Medical AI has entered a new stage where "application is king."